Timothy A. Whitehead

Timothy A. Whitehead

Auto-generated profile, based on publicly available information

Timothy A. Whitehead

Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI, USA.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2016 in Nature Methods
Verified
Journal Article
Closed access
PDF file
EWEmily E Wrenbeck
Emily E Wrenbeck
JKJustin R Klesmith
Justin R Klesmith
JSJames A Stapleton
James A Stapleton
AAAdebola Adeniran
Adebola Adeniran
KTKeith E J Tyo
Keith E J Tyo
TWTimothy A Whitehead
Timothy A Whitehead

14 February 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JKJustin R. Klesmith
Justin R. Klesmith
JBJohn-Paul Bacik
John-Paul Bacik
EWEmily E. Wrenbeck
Emily E. Wrenbeck
RMRyszard Michalczyk
Ryszard Michalczyk
TWTimothy A. Whitehead
Timothy A. Whitehead
Significance: Enzymes find utility as therapeutics and for the production of specialty chemicals. Changing the amino acid sequence of an enzyme can increase solubility, but many such mutations disrupt catalytic activity. To evaluate this trade-off, we developed an experimental system to evaluate the relative solubility for nearly all possible single point mutants for two model enzymes. We find that the tendency for a given solubility-enhancing mutation to disrupt catalytic activity depends, among other factors, on how far the position is from the catalytic active site and whether that mutation has been sampled during evolution. We develop predictive models to identify mutations that enhance solubility without disrupting activity with an accuracy of 90%. These results have biotechnological applications.

6 June 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
EWEmily E. Wrenbeck
Emily E. Wrenbeck
LALaura R. Azouz
Laura R. Azouz
TWTimothy A. Whitehead
Timothy A. Whitehead
Our lack of total understanding of the intricacies of how enzymes behave has constrained our ability to robustly engineer substrate specificity. Furthermore, the mechanisms of natural evolution leading to improved or novel substrate specificities are not wholly defined. Here we generate near-comprehensive single-mutation fitness landscapes comprising >96.3% of all possible single nonsynonymous mutations for hydrolysis activity of an amidase expressed in E. coli with three different substrates. For all three selections, we find that the distribution of beneficial mutations can be described as exponential, supporting a current hypothesis for adaptive molecular evolution. Beneficial mutations in one selection have essentially no correlation with fitness for other selections and are dispersed throughout the protein sequence and structure. Our results further demonstrate the dependence of local fitness landscapes on substrate identity and provide an example of globally distributed sequence-specificity determinants for an enzyme.

1 October 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CKCaitlin A. Kowalsky
Caitlin A. Kowalsky
MFMatthew S. Faber
Matthew S. Faber
ANAritro Nath
Aritro Nath
HDHailey E. Dann
Hailey E. Dann
VKVince W. Kelly
Vince W. Kelly
TWTimothy A. Whitehead
Timothy A. Whitehead
Knowledge of the fine location of neutralizing and non-neutralizing epitopes on human pathogens affords a better understanding of the structural basis of antibody efficacy, which will expedite rational design of vaccines, prophylactics, and therapeutics. However, full utilization of the wealth of information from single cell techniques and antibody repertoire sequencing awaits the development of a high-throughput, inexpensive method to map the conformational epitopes for antibody-antigen interactions. Here we show such an approach that combines comprehensive mutagenesis, cell surface display, and DNA deep sequencing. We develop analytical equations to identify epitope positions, and show the method effectiveness by mapping the fine epitope for different antibodies targeting TNF, Pertussis Toxin, and the cancer target TROP2. In all three cases, the experimentally determined conformational epitope was consistent with previous experimental datasets, confirming the reliability of the experimental pipeline. Once the comprehensive library is generated, fine conformational epitope maps can be prepared at a rate of four per day.

1 August 2017 in Current Opinion in Structural Biology
Verified
Journal Article
Closed access
EWEmily E Wrenbeck
Emily E Wrenbeck
MFMatthew S Faber
Matthew S Faber
TWTimothy A Whitehead
Timothy A Whitehead

20 June 2022 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
JBJesús Beltrán
Jesús Beltrán
PSPaul J. Steiner
Paul J. Steiner
MBMatthew Bedewitz
Matthew Bedewitz
SWShuang Wei
Shuang Wei
FPFrancis C. Peterson
Francis C. Peterson
TWTimothy A. Whitehead
Timothy A. Whitehead
A general method to generate biosensors for user-defined molecules could provide detection tools for a wide range of biological applications. Here, we describe an approach for the rapid engineering of biosensors using PYR1 (Pyrabactin Resistance 1), a plant abscisic acid (ABA) receptor with a malleable ligand-binding pocket and a requirement for ligand-induced heterodimerization, which facilitates the construction of sense–response functions. We applied this platform to evolve 21 sensors with nanomolar to micromolar sensitivities for a range of small molecules, including structurally diverse natural and synthetic cannabinoids and several organophosphates. X-ray crystallography analysis revealed the mechanistic basis for new ligand recognition by an evolved cannabinoid receptor. We demonstrate that PYR1-derived receptors are readily ported to various ligand-responsive outputs, including enzyme-linked immunosorbent assay (ELISA)-like assays, luminescence by protein-fragment complementation and transcriptional circuits, all with picomolar to nanomolar sensitivity. PYR1 provides a scaffold for rapidly evolving new biosensors for diverse sense–response applications.